Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

Russia has surpassed the United Arab Emirates as India's top naphtha supplier in the year to March 2025, as refiners ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The growing e-lifestyle Indian market gives producers an expanded reach and cost-efficient avenues for sales, while offering ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

India’s bond market just hit $2.69 trillion, but while retail participation has surged in the wake of SEBI's moves, there's ...

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling ...

De Beers’ MD Amit Pratihari discusses lab-grown diamonds, evolving consumer preferences, and strategic expansion plans in ...

TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial ...

India continued to exhibit strong momentum within the APAC region, with H2 2024 witnessing 88 per cent annual rise in ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...